BPA Call 36C24822A0029-36C24823N0766

Award Date 7/1/23
Potential Completion Date 6/30/24
Potential Value $151K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, valued at $826,186.14, is for providing prostate cancer testing services to the VA under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract has an ultimate completion date of June...
This is a $85,939.20 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company based in Irvine, California. The contract is for the provision of prostate cancer testing services under Option Three of the "PROSTATE CANCER TEST" program, with a performance period through June 30, 2026. The contract is not designated as a set-aside. This BPA call is part of a larger indefinite...
The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) call to Mdxhealth, Inc., a for-profit healthcare company, to provide Oncotype Prostate Cancer Testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II). The award has a potential value of $27,657.57 and a completion date of April 2, 2025. Mdxhealth has previously provided cancer testing services to the VA,...
This $319,293 firm-fixed-price federal contract was awarded by the Veterans Integrated Service Network (VISN) 17, a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. for the provision of Oncotype DX prostate cancer testing services. The contract was issued as a Blanket Purchase Agreement (BPA) call order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract, which allows the VA to procure these specialized diagnostic testing...
This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Mdxhealth, Inc., a for-profit organization that provides molecular diagnostic services and information to personalize the diagnosis and treatment of cancer. The contract is a Blanket Purchase Agreement (BPA) Call under the VA's existing Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract, with a potential value of $429,495.00. The contract is for proprietary...
This is a Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) for Oncotype Prostate testing services. The prime contractor is Mdxhealth, Inc., a healthcare company that provides specialized cancer diagnostic testing. The $204,347.52 fixed-price contract was awarded on May 1, 2023 and has an ultimate completion date of April 30, 2024. It was issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. This contract...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Mdxhealth, Inc., a for-profit organization, to provide proprietary genetic testing services in support of patient diagnosis, such as for cancer. The contract is a Blanket Purchase Agreement (BPA) Call under the VA's existing Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract has a potential value of $232,732.75 and a completion date of...
This is a federal contract award to Mdxhealth, Inc., a for-profit healthcare company, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract, a Blanket Purchase Agreement (BPA) call under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule, is valued at $430,183.13. The contract is for the provision of proprietary genetic testing services to support patient diagnosis, particularly for cancer, for the VA's Veterans Integrated...
This is a $443,440.90 firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 19 to MdxHealth, Inc., a for-profit organization. The BPA is for the provision of proprietary genetic testing services in support of patient diagnosis, particularly for cancer, under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The contract does...
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a multinational healthcare company that provides molecular diagnostic services and information to personalize the diagnosis and treatment of cancer. The $85,996.65 firm-fixed-price contract is a Blanket Purchase Agreement (BPA) call order under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for proprietary genetic...

This is a $151,131 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract is for the provision of prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and has a period of performance through June 30, 2024. Mdxhealth, Inc. has multiple existing Indefinite Delivery Vehicles (IDVs) with the VA, including a $4.8 million BPA for Oncotype DX prostate testing and a $539,944.76 BPA for MDX health testing, which allow the VA to efficiently procure the company's specialized cancer diagnostic services across its national network of healthcare facilities. This contract was not set aside for any specific business type.

Generated 6/26/25, 9:44 AM